Skip to main content

Sabra Health Care REIT Inc

For the period ended Dec 31, 2023. Filed Feb 27, 2024.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2023 · Filed Feb 27, 2024

SBRA$21.47+2.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Consolidated Balance Sheets

December 31,
20232022
Assets
Real estate investments, net of accumulated depreciation of $1,021,086 and $913,345 as of December 31, 2023 and 2022, respectively$4,617,261$4,959,343
Loans receivable and other investments, net420,624411,396
Investment in unconsolidated joint ventures136,843134,962
Cash and cash equivalents41,28549,308
Restricted cash5,4344,624
Lease intangible assets, net30,89740,131
Accounts receivable, prepaid expenses and other assets, net133,806147,908
Total assets$5,386,150$5,747,672
Liabilities
Secured debt, net$47,301$49,232
Revolving credit facility94,429196,982
Term loans, net537,120526,129
Senior unsecured notes, net1,735,2531,734,431
Accounts payable and accrued liabilities136,981142,259
Lease intangible liabilities, net32,53242,244
Total liabilities2,583,6162,691,277
Commitments and contingencies (Note 15)
Equity
Preferred stock, $0.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of December 31, 2023 and 2022——
Common stock, $0.01 par value; 500,000,000 shares authorized, 231,266,020 and 231,009,295 shares issued and outstanding as of December 31, 2023 and 2022, respectively2,3132,310
Additional paid-in capital4,494,7554,486,967
Cumulative distributions in excess of net income(1,718,279)(1,451,945)
Accumulated other comprehensive income23,74519,063
Total equity2,802,5343,056,395
Total liabilities and equity$5,386,150$5,747,672
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.